M&A Deal Summary |
|
---|---|
Date | 2016-12-06 |
Target | Mayne Pharma Group - 15 Mayne Pharma Products |
Sector | Medical Products |
Buyer(s) | H2-Phama |
Sellers(s) | Mayne Pharma |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
H2-Phama LLC is a privately-held pharmaceutical company focused on the sales, marketing and development of generic pharmaceuticals.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Australia) | 1 of 1 |
Year (2016) | 1 of 1 |
Category | Company |
---|---|
Sector | Life Science |
Revenue | 388M AUD (2024) |
Mayne Pharma is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services. Mayne Pharma is based in Salisbury South, Australia.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 2 |
Country (Australia) | 1 of 1 |
Year (2016) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-02-24 |
Actavis Doryx Brand and Related Assets
United States Actavis Doryx Brand and Related Assets comprises the Doryx trademark, marketing materials, select product inventory, and related medical and technical data. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-09 |
Metrics Contract Services
Greenville, North Carolina, United States Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics provides formulation development, analytical testing, and commercial manufacturing from its single-campus facility in Greenville, North Carolina. |
Sell | $475M |